A non-radical reaction between peroxysulfates and phenolic compounds, as important structural moieties of natural organic matters, has been reported recently, implying new opportunities for environmental remediation without need for catalyst or energy input. However, this approach seems to be ineffective for halogenated aromatic compounds, an important disinfection by-products (DBPs). Here, we shed light on the interactions between peroxymonosulfate (PMS) and chlorophenols and the influential factors. The results show that the chlorophenols transformation kinetics were highly dependent on the solution pH and chlorophenol species: raising the pH significantly accelerated the chlorophenols degradation, and at alkaline pH the removal rates of different chlorophenols were in the order of trichlorophenol > dichlorophenol > chlorophenol > tetrachlorophenol. The faster degradation of pollutants with more chlorine groups was mainly due to their relatively higher dissociation degree, which favors a direct pollutant-PMS interaction to generate radicals for their degradation. The chlorophenol degradation intermediate (i.e. benzoquinone) further mediated the generation of singlet oxygen at alkaline pH, thereby contributing to accelerated pollutant removal. The slower degradation of tetrachlorophenol than other chlorophenols was likely due to its strong electrostatic epulsion to PMS which restricted the reaction. Our work unveils the chlorophenols degradation mechanisms in PMS reaction system, which may facilitate a better understanding and optimization of advanced oxidation processes for pollution control to reduce potential DBPs accumulation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.scitotenv.2019.02.039 | DOI Listing |
Small
January 2025
School of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai, 200093, P. R. China.
Chlorophenols are difficult to degrade and mineralize by traditional advanced oxidation processes due to the strong electronegativity of chlorine. Here, a dual-site atomically dispersed catalyst (FeMoNC) is reported, which Fe/Mo supported on mesoporous nitrogen-doped carbon is prepared through high-temperature migration. The FeMoNC exhibits a high dechlorination rate of 93.
View Article and Find Full Text PDFMicrobiome
January 2025
Instituto de Investigación de La Viña y El Vino, Escuela de Ingeniería Agraria, Universidad de León, Avenida de Portugal, 41, León, 24009, Spain.
Int J Mol Sci
January 2025
Department of Anatomy, Animal Physiology and Biophysics, Faculty of Biology, University of Bucharest, Splaiul Independentei 91-95, 050095 Bucharest, Romania.
Cenobamate is a new and highly effective antiseizure compound used for the treatment of adults with focal onset seizures and particularly for epilepsy resistant to other antiepileptic drugs. It acts on multiple targets, as it is a positive allosteric activator of γ-aminobutyric acid type A (GABA) receptors and an inhibitor of neuronal sodium channels, particularly of the late or persistent Na current. We recently evidenced the inhibitory effects of cenobamate on the peak and late current component of the human cardiac isoform hNav1.
View Article and Find Full Text PDFMicroorganisms
December 2024
Institute of Biochemistry and Physiology of Microorganisms, Federal Research Center "Pushchino Scientific Center for Biological Research of Russian Academy of Sciences" (FRC PSCBR RAS), 142290 Pushchino, Russia.
Phenol and its chlorinated derivatives are introduced into the environment with wastewater effluents from various industries, becoming toxic pollutants. Phenol-degrading bacteria are important objects of research; among them, representatives of the genus are often highlighted as promising. Strain 7Ba was isolated by enrichment culture.
View Article and Find Full Text PDFBiomolecules
December 2024
Department of Anatomy, Animal Physiology and Biophysics, Faculty of Biology, University of Bucharest, Splaiul Independentei 91-95, 050095 Bucharest, Romania.
Cenobamate is a novel third-generation antiepileptic drug used for the treatment of focal onset seizures and particularly for multi-drug-resistant epilepsy; it acts on multiple targets: GABA receptors (EC 42-194 µM) and persistent neuronal Na currents (IC 59 µM). Side effects include QT interval shortening with >20 ms, but not <300 ms. Our in vitro cardiac safety pharmacology study was performed via whole-cell patch-clamp on HEK293T cells with persistent/inducible expression of human cardiac ion channel isoforms hNav1.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!